Drug attitudes and treatment adherence in a clinical trial comparing haloperidol and olanzapine in first episode schizophrenia

被引：0

作者：

Centorrino, F

Hamer, RM

Tohen, M

Glick, ID

McEvoy, JP

Perkins, DO

Sharma, T

Zipursky, RM

Kahn, R

Gur, RE

Green, AI

Nemeroff, CB

Rothschild, A

Strakowski, SM

Tollefson, GD

Lieberman, JA

机构：

[1] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02178 USA

[2] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA

[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA

[4] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA

[5] John Umstead Hosp, Butner, NC USA

[6] Stonehouse Hosp, Clin Neurosci Res Ctr, Dartford, Kent, England

[7] Univ Toronto, Dept Psychiat, Toronto, ON, Canada

[8] Univ Utrecht, Med Ctr, Dept Psychiat, Utrecht, Netherlands

[9] Univ Penn, Neuropsychiat Sect, Philadelphia, PA 19104 USA

[10] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA

[11] Univ Massachusetts, Sch Med, Ctr Psychopharmacol Res & Treatment, Worcester, MA USA

[12] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA

来源：

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

526

引用

页码：186S / 186S

页数：1